Dupilumab Efficacy on Exacerbations and Lung Function by Cough and Sputum Score: Pooled Results from Phase 3 BOREAS and NOTUS
Chronic cough and sputum production are prevalent in chronic obstructive pulmonary disease (COPD) and risk factors for exacerbations and mortality. Dupilumab, a human monoclonal antibody, blocks interleukin (IL)-4 and IL-13 signaling, key and central drivers of type 2 inflammation. This post hoc analysis of pha...